Omnicell earnings were $20.4M for the trailing 12 months ending Mar 31, 2026, with -4.3% growth year over year. The latest OMCL earnings report on Mar 31, 2026 announced Q1 2026 earnings of $11.4M, down 660.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OMCL reported annual earnings of $2.1M, with -83.6% growth.
OMCL past earnings growth
How has OMCL's earnings growth performed historically?
On OMCL's earnings call on Apr 23, 2026, Omnicell (NASDAQ: OMCL) reported Q1 2026 earnings per share (EPS) of $0.25, up 266.67% year over year. Total OMCL earnings for the quarter were $11.36 million. In the same quarter last year, Omnicell's earnings per share (EPS) was -$0.15.
As of the last Omnicell earnings report, Omnicell is currently profitable. Omnicell's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $20.43 million, a 3.55% decrease year over year.
What was OMCL's earnings growth in the past year?
As of Omnicell's earnings date in Apr 23, 2026, Omnicell's earnings has grown -4.35% year over year. This is 74.29 percentage points lower than the US Health Information Services industry earnings growth rate of 69.94%. OMCL earnings in the past year totalled $20.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.